Wilson Therapeutics
id:
wilson-therapeutics-269-790459
title:
Wilson Therapeutics
text:
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for rare diseases. The company is listed in the Mid-Cap segment on Nasdaq Stockholm with the stock ticker WTX. Wilson Therapeutics' lead product, Decuprate, is the proprietary bis-choline salt of tetrathiomolybdate. Decuprate is initially being developed as a novel treatment for Wilson's disease, a rare genetic disease that affects approximately 1 in 30,000, causing copper overload in th
brand slug:
wiki
category slug:
encyclopedia
description:
Swedish biopharmaceutical company
original url:
https://en.wikipedia.org/wiki/Wilson_Therapeutics
date created:
date modified:
2023-12-22T01:56:23Z
main entity:
{"identifier":"Q18395077","url":"https://www.wikidata.org/entity/Q18395077"}
image:
fields total:
13
integrity:
14